Bristol-Myers Squibb, Amgen and Abbott Labs all recently raised their dividends and should prosper amid the aging population.
Don't let Boeing's problems lead you to ignore attractive opportunities in the sector.
Here we unpack the year-end promises of MSC Industrial Direct and Vornado Realty Trust.
This firm is a notable outlier within the financial sector.
Altria has moved up from Dividend Aristocrat to King, but new legislation could threaten the tobacco company and others.
AT&T has a history of dividend increases and with its Time Warner merger, lots of growth potential.
This is the fifth consecutive quarter that FDX in some way reduced forward guidance.
The next six months set up very well for this name with mid-single-digits growth and consistency in earnings and cash flow.
Zoetis Inc. shares are up more than 45% year-to-date and the company appears on the path to becoming a Contender.
Hey income investors, this MLP has increased its distribution for 61 consecutive quarters.